Article

marketwatch.com on 2020-09-17 18:59

How this Nasdaq-U.K.-listed Chinese biotech is revolutionizing cancer treatment

Chi-Med has been granted three U.S. Food and Drug Administration Fast Track Designations for its cancer drugs.

Related news